Nrx Pharmaceuticals Inc (NRXP)

$0.76 0.01 (1.33%)

15:38 EDT NRXP Stock Quote Delayed 30 Minutes

Why Is NRx Pharmaceuticals (NRXP) Stock Down 60% Today?

By Chris MacDonald, InvestorPlace Contributor May 26, 2022

Today, investors in NRx Pharmaceuticals and NRXP stock have seen heavy selling pressure as a key trial was stopped due to futility.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

NRXP Stock Alert: The Covid-19 News Lifting NRx Pharmaceuticals Today

RLFTF Stock Alert: What Is Going on With Relief Therapeutics Today?

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 250,846

Day's Range $0.71 - $0.77

52-Week Range $0.49 - $2.96

Dividend & Yield N/A (N/A)

NRXP Stock Predictions, Articles, and Nrx Pharmaceuticals Inc News

From InvestorPlace
From the Web

NRXP Stock Alert: What Is Going on With NRx Pharmaceuticals Today?

By Larry Ramer, InvestorPlace Contributor Dec 29, 2021

NRx is seeking to have the FDA grant its coronavirus treatment breakthrough designation, based on new, favorable data on the drug. NRXP stock is climbing on the news.

NRXP Stock Surges on Latest Covid-19 Update From NRx Pharmaceuticals

By Joel Baglole, InvestorPlace Contributor Nov 29, 2021

News that NRx Pharmaceuticals' Covid-19 treatment helps improve survivability in critical patients is sending NRXP stock higher today.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Nov 29, 2021

I hope you got your rest out over the holiday weekend because we're starting off Monday with the biggest pre-market stock movers!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Nov 3, 2021

Good morning, trader! We're starting the day off right with a dive into the biggest pre-market stock movers for Wednesday!

NRXP Stock: The Critical Covid-19 Trial Results That Have NRx Pharma Rocketing Higher

By William White, InvestorPlace Writer Oct 14, 2021

NRX Pharmaceuticals (NRXP) stock is surging higher on Thursday thanks to recent results from a clinical trial of its Covid-19 treatment.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Oct 13, 2021

We're at the halfway point of the trading week and that has us checking in on the biggest pre-market stock movers for Wednesday!

NRXP Stock Is Soaring Today Thanks to This Big FDA Catalyst

By Samuel O'Brient, InvestorPlace Financial News Writer Oct 12, 2021

NRx Pharmaceuticals got some good news from the FDA and its shareholders are happy as NRXP stock enjoys a day of impressive gains.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Sep 7, 2021

It's been a long holiday weekend but we're getting right back into the swing of things with a look at the pre-market stock movers for today!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Aug 24, 2021

Good morning, investor! We're getting ready for another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jul 23, 2021

We're gearing up for one final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday!

NRXP Stock: This Covid-19 Treatment Could Prime NRx Pharmaceuticals for Big Gains

By Brenden Rearick, InvestorPlace Financial News Writer Jul 22, 2021

NRXP stock came to investors' attention last year with its Covid-19 treatment. Now, it's looking like a great play as it eyes up EUA.

NRXP Stock: The ‘Cykotine Storm’ Drug News Sending NRx Pharma Shares Soaring

By Nick Clarkson, Web Editor Jul 19, 2021

Shares of NRXP stock are taking off on Monday after the pharmaceutical company reported positive results regarding its Zyesami trial.

BRPA Stock: 14 Things to Know About Big Rock Partners and the NeuroRx SPAC Merger

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Dec 22, 2020

BRPA stock is shooting higher as investors process news that Big Rock Partners will take NeuroRx public. Here's what to know.

NRx says FDA suggests broadening use of bipolar depression disorder drug in trial

From Seeking Alpha Feb 13, 2023

NRx Pharmaceuticals (NRXP) on Monday reported the minutes of a Type B meeting with the U.S. Food and Drug Administration's ((FDA)) Division of Psychiatry Products held on Jan

NRXP stock gains on FDA comments regarding lead asset (NASDAQ:NRXP)

From Seeking Alpha Jan 19, 2023

NRX Pharmaceuticals (NRXP) traded highe Thursday after announcing FDA comments on its plans to develop the lead candidate NRX-101 for suicidal bipolar depression. Read the full story here.

NRXP stock gains as Phase 3 trial for bipolar candidate starts (NASDAQ:NRXP)

From Seeking Alpha Jan 3, 2023

NRx Pharmaceuticals (NRXP) gained after announcing the initiation of a Phase 3 trial for NRX-101, an investigational therapy targeted at bipolar depression. Read the full story here.

Analysts Offer Insights on Healthcare Companies: NRX Pharmaceuticals (NRXP) and Arcutis Biotherapeutics (ARQT)

From TipRanks Nov 15, 2022

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on NRX Pharmaceuticals (

Relief, NRx reach settlement over COVID-19 therapy aviptadil

From Seeking Alpha Nov 14, 2022

Relief Therapeutics (RLFTF) (RLFTD) and NRx Pharmaceuticals (NRXP) said they signed settlement agreements to resolve their pending litigation related to experimental COVID-19...

H.C. Wainwright Sticks to Their Buy Rating for NRX Pharmaceuticals (NRXP)

From TipRanks Sep 8, 2022

H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on NRX Pharmaceuticals (NRXP – Research Report) today and set a price target of $2.00. The c...

Nrx Pharmaceuticals Inc (NRXP)

Why Is NRx Pharmaceuticals (NRXP) Stock Down 60% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

NRXP Stock Alert: The Covid-19 News Lifting NRx Pharmaceuticals Today

RLFTF Stock Alert: What Is Going on With Relief Therapeutics Today?

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Nrx Pharmaceuticals Inc (NRXP)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

NRXP Stock Predictions, Articles, and Nrx Pharmaceuticals Inc News

Subscriber Sign in